Trump Picks White House Aide Dr. Heidi Overton to Lead FDA
核心洞察
President Trump has selected Dr. Heidi Overton (搜索), deputy director of the White House Domestic Policy Council, to serve as the next FDA commissioner.
Overton will require Senate confirmation and face questions from the Senate health committee before assuming the role.
She succeeds Dr. Marty Makary, who resigned in May, leaving unfinished work on ultra-processed foods, antidepressants, and COVID-19 shots.
President Donald Trump has selected Dr. Heidi Overton (搜索), a deputy director of the White House Domestic Policy Council, to lead the Food and Drug Administration (搜索), according to the Associated Press. Overton, described as a trusted figure in the administration who has worked on several of Trump's health initiatives, will need Senate confirmation and face questions from the Senate health committee before assuming the role of FDA commissioner.
Referring to a "Dr. Heidi" in a Truth Social post, Trump called Overton a smart and respected "rockstar" who would deliver on his priorities of faster cures, innovation, lower drug prices and more wins for Health Secretary Robert F. Kennedy Jr.'s Make America Healthy Again movement.
The nomination follows the resignation of the previous FDA head, Dr. Marty Makary, who stepped down in May. Makary's departure left unfinished projects including work on ultra-processed foods, antidepressants, and COVID-19 shots.
Overton will face challenges balancing Trump's priorities, traditional Republican interests, and Health Secretary Robert F. Kennedy Jr.'s anti-corporate stance, according to the report. Her confirmation process will require navigating these competing pressures as she prepares to assume leadership of the agency responsible for regulating food, drugs, and medical products in the United States.